A measuring device, filtering method, manufacturing method and production device for particles in semiconductor liquid
By using a device that provides a narrow section in semiconductor component manufacturing, the problem of the influence of bubbles in liquid microparticles is solved, and the measurement accuracy is improved.
Patent Information
- Application Number
- CN202410928678.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-11
- Publication Date
- 2024-12-06
- Estimated Expiration
- 2044-07-11
AI Technical Summary
In the existing semiconductor component manufacturing, liquid microparticle detection devices are susceptible to bubbles during detection, resulting in a decrease in measurement accuracy and fail to effectively solve the impact of bubbles on measurement results.
A device including a liquid tank, a flow path, a liquid ejector, a filter and a measuring device is designed, and a narrow section (constructed by a diaphragm valve) is provided in the first flow path to improve the drug liquid in the second flow path. Pressure suppresses bubble size, thereby improving the accuracy of particle measurement.
By setting up a narrow section, the size of bubbles in the medicine liquid is effectively suppressed, the accuracy of particle measurement is improved, and the impact of bubbles on the measurement results is reduced.
Smart Images

Figure CN118464734B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to a measuring device, a filtering method, a manufacturing method and a production device for particles in a semiconductor manufacturing solution used in the manufacture of semiconductor elements, etc., and in particular to a measuring device, a filtering method, a manufacturing method and a production device for particles in a semiconductor manufacturing solution for measuring the number of particles contained in the semiconductor manufacturing solution. Background Art
[0002] As a method for manufacturing a semiconductor element, the following method is known.
[0003] First, in order to form semiconductor elements such as IC (Integrated Circuit) and LSI (Large Scale Integrated Circuit), a resist as a liquid medicine is sprayed onto a semiconductor wafer to form a resist film on the semiconductor wafer. Then, the resist film is exposed and developed to form a pattern portion. Then, etching is performed to form a pattern on the semiconductor wafer. In addition, in order to flatten the semiconductor wafer, a chemical mechanical polishing (CMP: Chemical Mechanical Polishing) process is also performed. After the above-mentioned etching and CMP processes are performed, the semiconductor wafer is cleaned using a liquid medicine (cleaning solution).
[0004] Various chemical solutions are used in the manufacture of semiconductor elements, etc. If the resist contains particles, it will cause defects in the resist film. In addition, when the chemical solution is used for cleaning, a sufficient cleaning effect cannot be obtained. Therefore, the microparticles contained in the chemical solution are measured.
[0005] For example, Japanese Patent Gazette No. 9-05228 describes a device for detecting particles in liquid, which detects particles contained in liquid. The device for detecting particles in liquid comprises: a liquid supply pipe, which allows liquid to flow; a light scattering particle detection unit, which is arranged in the liquid supply pipe; and a calculation unit, which calculates the number of particles per unit flow contained in the liquid based on a detection signal from the particle detection unit and the flow rate of the liquid.
[0006] When the liquid microparticle detection device of the patent document is used to detect microparticles in liquid, if there are bubbles in the liquid, the bubbles may be measured (counted) as particles. In this case, the measured value of the microparticles also includes the number of bubbles, resulting in reduced measurement accuracy.
[0007] However, in the liquid microparticle detection device of this patent document, no consideration is given to air bubbles which may cause a decrease in measurement accuracy.
[0008] In view of this, those skilled in the art need to improve the existing detection device to reduce the influence of bubbles on the measurement accuracy during detection. Summary of the invention
[0009] The main purpose of the present application is to provide a measuring device, a filtering method, a manufacturing method and a production device for particles in a semiconductor solution, so as to reduce the influence of bubbles on the measurement accuracy during detection.
[0010] In order to achieve the above-mentioned purpose, in a first aspect, the present application provides a device for measuring particles in a semiconductor liquid, comprising:
[0011] A liquid tank for storing chemical solutions used in semiconductor manufacturing;
[0012] The liquid tank has an outflow end for the liquid medicine to flow out of the liquid tank and an inflow end for the liquid medicine to flow into the liquid tank;
[0013] A first flow path connecting the outflow end and the inflow end for the liquid medicine to flow;
[0014] a second flow path extending from a branch point in the first flow path to a confluence point in the first flow path that is located downstream of the branch point;
[0015] a liquid ejector disposed in the first flow path on the upstream side of the branch point, so that the liquid medicine in the liquid tank flows into the first flow path from the outflow end toward the inflow end;
[0016] a filter disposed between the liquid ejector and the branch point in the first flow path; and
[0017] a measuring device disposed in the second flow path and configured to count the number of particles contained in the drug solution in the second flow path,
[0018] In the first flow path, a narrow passage is provided between the branch point and the confluence point.
[0019] The cross-sectional area of the narrow passage portion is smaller than the cross-sectional area of the first passage on the upstream side of the branch point of the first passage.
[0020] A further improvement is that the narrow path portion is formed by a valve.
[0021] A further improvement is that the valve is a diaphragm valve.
[0022] A further improvement is that the diaphragm valve is an air-operated flow regulating valve.
[0023] As a further improvement, a ratio of a cross-sectional area of the narrow passage portion to a cross-sectional area of the first passage located upstream of the branch point of the first passage is equal to or less than 0.50.
[0024] As a further improvement, the narrow passage portion is provided in the first flow path at a position closer to the branch point than a middle position between the branch point and the confluence point.
[0025] As a further improvement, a ratio of a cross-sectional area of the second flow path to a cross-sectional area of the first flow path on an upstream side of the branch point of the first flow path is 0.25 or less.
[0026] A further improvement is that the liquid medicine is a cleaning liquid.
[0027] A further improvement is that the chemical solution is a cleaning solution used in cleaning performed after chemical mechanical polishing.
[0028] A further improvement is that the drug solution contains a surfactant.
[0029] A further improvement is that the drug solution contains carboxylic acid and phosphonic acid.
[0030] A further improvement is that the drug solution is obtained by mixing two or more raw materials in the liquid tank.
[0031] In order to achieve the above-mentioned purpose, in a second aspect, the present application provides a device for producing a chemical solution for semiconductor manufacturing, comprising the above-mentioned measuring device.
[0032] In order to achieve the above-mentioned purpose, in a third aspect, the present application provides a method for filtering a medicinal liquid, comprising a step of filtering the medicinal liquid using the above-mentioned measuring device.
[0033] In order to achieve the above-mentioned purpose, in a fourth aspect, the present application provides a method for manufacturing a medicinal solution, which comprises a step of mixing two or more raw materials using the above-mentioned measuring device to manufacture the medicinal solution.
[0034] The present invention provides a measuring device, filtering method, manufacturing method and production device for manufacturing particles in semiconductor liquid. Compared with the prior art, its beneficial effect is that a narrow path portion is set between the branch point and the confluence point of the first flow path, that is, a diaphragm valve is set, thereby increasing the pressure of the liquid entering the second flow path, thereby suppressing the size of the bubbles contained in the liquid in the second flow path. The bubble size becomes smaller due to the increase in pressure, thereby ensuring the accuracy of the detection. BRIEF DESCRIPTION OF THE DRAWINGS
[0035] The drawings constituting a part of this application are used to provide a further understanding of this application, so that other features, purposes and advantages of this application become more obvious. The schematic embodiment drawings and their descriptions of this application are used to explain this application and do not constitute an improper limitation on this application. In the drawings:
[0036] Figure 1 This is a schematic diagram of an example of a device for measuring particles in a semiconductor chemical solution according to an embodiment of the present invention.
[0037] Among them: 10: a measuring device for manufacturing particles in a semiconductor liquid; 12: a liquid tank; 14: a first flow path; 14a: a flow path; 14n: a path portion; 15: a first pipe; 15a: a straight pipe portion; 15e: a curved portion; 16: a second flow path; 17: a second pipe; 18: a liquid ejector; 20: a filter; 21: a diaphragm valve; 22: a measuring device; 24: a discharge flow path; 24a: a straight portion; 24b : bend; 25: discharge piping; 25a: straight pipe; 25b: bend; 26: valve; 27: control unit; 28: container; 29: raw material supply unit; 30: first tank; 31a, 33a, 35a: piping; 31b, 33b, 35b: pump; 31c, 33c, 35c: valve; 32: second tank; 34: third tank; Pc: confluence point; Pd: outflow end; Pe: inflow end; Pi: drug solution inlet; Pj: branch point; Po: drug solution outlet; S: area; X1, X2: length. DETAILED DESCRIPTION
[0038] Hereinafter, the particle measuring device for semiconductor manufacturing chemical solution, the filtering method for semiconductor manufacturing chemical solution, and the manufacturing method for semiconductor manufacturing chemical solution of the present invention will be described in detail based on the preferred embodiments shown in the drawings.
[0039] In addition, the following drawings are used to illustrate the measuring device for manufacturing particles in semiconductor solution, but the structure of the measuring device for manufacturing particles in semiconductor solution shown below is simplified for the purpose of illustrating the present invention, and the present invention is not limited to the structure of the drawings shown below.
[0040] In addition, below, "to" indicating a numerical range includes the numerical values described on both sides. For example, the so-called ε is a numerical value εα to a numerical value εβ, which means that the range of ε is a range including the numerical values εα and εβ, and if expressed in mathematical symbols, it is εα≤ε≤εβ.
[0041] In addition, as for specific angles, parallelism and orthogonality, unless otherwise specified, they are within the error range generally allowed in the corresponding technical field. Also, as for length, temperature and pressure, unless otherwise specified, they are within the error range generally allowed in the corresponding technical field.
[0042] In addition, in this specification, each component can be used alone as a substance equivalent to each component, or two or more substances can be used in combination. Here, when two or more substances are used in combination for each component, unless otherwise specified, the content of the component refers to the total content of the substances used in combination.
[0043] Device for measuring particles in chemical solutions used in semiconductor manufacturing
[0044] Figure 1 This is a schematic diagram showing an example of a device for measuring particles in a semiconductor chemical solution according to an embodiment of the present invention.
[0045] Figure 1 The device 10 for measuring particles in a semiconductor manufacturing chemical solution is an example of a device for measuring particles in a semiconductor manufacturing chemical solution. The device 10 for measuring particles in a semiconductor manufacturing chemical solution measures the number of particles in the chemical solution during the process of manufacturing the semiconductor manufacturing chemical solution.
[0046] The device 10 for measuring particles in a semiconductor chemical solution includes a liquid tank 12 , a first flow path 14 , a second flow path 16 , a liquid ejector 18 , a filter 20 , a measuring device 22 , a discharge flow path 24 , a valve 26 , a control unit 27 , and a container 28 .
[0047] The liquid tank 12 is a component for storing chemical liquid (not shown) for semiconductor manufacturing. The size, capacity, structure and material of the liquid tank 12 are not particularly limited as long as it can store the chemical liquid as described above, and a liquid tank corresponding to the composition and amount of the chemical liquid can be used appropriately.
[0048] The liquid tank 12 includes an outflow end Pd through which the chemical solution flows out of the liquid tank 12 , and an inflow end Pe through which the chemical solution flows into the liquid tank 12 .
[0049] The first flow path 14 is a flow path that connects the outflow end Pd and the inflow end Pe of the liquid tank 12 and allows the drug solution to flow. The drug solution discharged from the outflow end Pd of the liquid tank 12 returns to the liquid tank 12 through the first flow path 14 and flows into the liquid tank 12 again from the inflow end Pe. That is, the drug solution in the liquid tank 12 circulates through the first flow path 14. Figure 1 In the embodiment, the first flow path 14 is configured in a quadrilateral shape, having a straight flow path and four bends. The bend angle of the bend is, for example, 90°. Although the straight flow paths are arranged relative to each other, the extending directions of the two straight flow paths relative to each other are parallel.
[0050] The first flow path 14 is constituted by, for example, a first pipe 15. Strictly speaking, the internal space of the first pipe 15 forms the first flow path 14. The first pipe 15 has a straight pipe portion and four bent pipe portions (bends) constituting a straight flow path, similarly to the first flow path 14. The bending angle of the bent pipe portion is, for example, 90°. In the first pipe 15, the extending directions of the two straight pipe portions facing each other are parallel. For example, in the first pipe 15, the cross-sectional shape in the direction orthogonal to the extending direction thereof is circular. In addition, in the first flow path 14, the cross-sectional shape orthogonal to the extending direction thereof is also circular.
[0051] The first pipe 15 is connected to the outflow end Pd and the inflow end Pe of the liquid tank 12 .
[0052] In the first flow path 14 , the side closer to the outflow end Pd of the liquid tank 12 is defined as the upstream side, and the side closer to the inflow end Pe is defined as the downstream side.
[0053] The first flow path 14 is not particularly limited to being arranged in a rectangular shape as long as it can circulate the drug solution in the liquid tank 12. The first flow path 14 may be arranged in a circular ring shape, for example. That is, the laying path of the first flow path 14 can be determined arbitrarily.
[0054] The second channel 16 is a channel extending from the branch point Pj in the first channel 14 to the confluence point Pc located downstream of the branch point Pj in the first channel 14. The second channel 16 is provided outside the region S surrounded by the first channel 14 and the liquid tank 12, for example.
[0055] exist Figure 1 , the branch point Pj and the confluence point Pc are arranged in a linear flow path 14a in the linear flow paths of the first flow path 14. That is, the second flow path 16 is connected to the flow path 14a. The second flow path 16 is configured in a quadrilateral shape together with a part of the flow path 14a, and has three linear flow paths and two curved portions. The angle of the curved portion is, for example, 90°. Among the three linear flow paths constituting the second flow path 16, two linear flow paths are opposite, and the remaining linear flow path is opposite to the flow path 14a. The extension directions of the two linear flow paths opposite to each other are parallel.
[0056] The second flow path 16 is constituted by, for example, the second pipe 17. Strictly speaking, the internal space of the second pipe 17 forms the second flow path 16. The second pipe 17 is connected to a position corresponding to the branch point Pj of the first pipe 15 and a position corresponding to the confluence point Pc of the first pipe 15. For example, in the second pipe 17, the cross-sectional shape in the direction perpendicular to the extending direction thereof is circular. In addition, in the second flow path 16, the cross-sectional shape perpendicular to the extending direction thereof is also circular.
[0057] The second pipe 17 has three straight pipe portions and two bent pipe portions (bends) constituting a straight flow path, similarly to the second flow path 16. The bending angle of the bent portion is, for example, 90°. Of the three straight pipe portions constituting the second pipe 17, two straight pipe portions are opposite to each other, and the remaining straight pipe portion is opposite to the straight pipe portion 15a of the first pipe 15. The extending directions of the two straight pipe portions opposite to each other are parallel.
[0058] The second flow path 16 is arranged in a quadrilateral shape together with a part of the flow path 14a, but the present invention is not particularly limited thereto. The second flow path 16 may be arranged in a circular ring shape, for example. That is, the laying path of the second flow path 16 can be arbitrarily determined.
[0059] The narrow passage 14n is provided between the branch point Pj and the confluence point Pc in the first flow path 14. The cross-sectional area of the narrow passage 14n is smaller than the cross-sectional area of the first flow path 14 on the upstream side of the branch point Pj of the first flow path 14.
[0060] In the first flow path 14, by providing the narrow passage 14n between the branch point Pj and the confluence point Pc, the pressure in the second flow path 16 becomes higher. As a result, it is possible to prevent the size of bubbles contained in the drug solution in the second flow path 16 from being reduced due to the higher pressure, so that the bubbles can be measured as particles by the measuring device 22.
[0061] As a measuring device for accurately measuring the number of particles, for example, a means of providing a pressure-boosting pump on the upstream side of the measuring device 22 in the second flow path 16 can be considered. In this way, the pressure in the second flow path 16 can be further increased, and the size of the bubbles contained in the liquid medicine in the second flow path 16 becomes smaller due to the pressure, so that the bubbles can be suppressed from being measured as particles by the measuring device 22. However, when this method is used, other problems arise, such as pressure fluctuations (pulsations) in the second flow path 16 due to the pressure-boosting pump, and the need to provide a power source for the pump.
[0062] In contrast, Figure 1 If a method is adopted in which a narrow passage 14n is provided between the branch point Pj and the confluence point Pc in the first flow path 14, as in the device 10 for measuring particles in a semiconductor liquid, the above-mentioned problem will not occur.
[0063] The cross-sectional area of the narrow passage 14n is not particularly limited, but is preferably 10 to 6600 mm. 2 , more preferably 10 to 4400 mm 2 , more preferably 10 to 2200 mm 2 If the cross-sectional area of the narrow passage 14n is 10 mm 2 If the cross-sectional area of the narrow passage 14n is 6600 mm 2The following will provide more excellent effects of the present invention.
[0064] The cross-sectional area of the narrow passage 14n is the area of the flow path located in the narrow passage 14n in the direction perpendicular to the direction in which the first flow path 14 between the branch point Pj and the confluence point Pc extends. The cross-sectional area of the narrow passage 14n can be calculated by a known procedure. For example, as described later, when the narrow passage 14n is composed of a diaphragm valve 21, the cross-sectional area can be calculated based on the shape of the diaphragm and the amount of pressure of the driving part.
[0065] The cross-sectional area of the first flow path 14 on the upstream side of the branch point Pj of the first flow path 14 is not particularly limited, but is preferably 30 to 8800 mm. 2 .
[0066] The cross-sectional area of the first flow path 14 upstream of the branch point Pj of the first flow path 14 is the cross-sectional area of the internal space of the first pipe 15 in the direction perpendicular to the direction in which the first flow path 14 extends upstream of the branch point Pj.
[0067] The cross-sectional area of the first flow path 14 (excluding the narrow passage 14n) on the downstream side of the branch point Pj of the first flow path 14 is not particularly limited, but is preferably 30 to 8800 mm. 2 .
[0068] The cross-sectional area downstream of the branch point Pj of the first flow path 14 (excluding the narrow passage 14n) is the cross-sectional area of the internal space of the first pipe 15 in a direction orthogonal to the direction in which the first flow path 14 extends downstream of the branch point Pj.
[0069] The cross-sectional area of the second flow path 16 is not particularly limited, but is preferably 30 to 600 mm 2 .
[0070] The cross-sectional area of the second flow path 16 is the cross-sectional area of the internal space of the second pipe 17 in the direction orthogonal to the direction in which the second flow path 16 extends.
[0071] exist Figure 1 In the example of the embodiment, the narrow passage 14n is formed by a diaphragm valve 21. The diaphragm valve 21 is a type of valve, and adjusts the flow rate of the liquid medicine flowing in the narrow passage 14n by opening and closing the diaphragm (membrane) as a valve body. Therefore, the cross-sectional area of the narrow passage 14n in the first flow path 14 increases or decreases by opening and closing the diaphragm of the diaphragm valve 21.
[0072] In addition, when the diaphragm valve 21 is used in the narrow passage 14n, the sealing performance, corrosion resistance and maintainability in the narrow passage 14n are excellent, and the operating torque is relatively low, so there is an advantage that the chemical solution is not likely to remain after use. Therefore, the diaphragm valve 21 is preferably used to manufacture chemical solutions for semiconductor manufacturing that require high purity.
[0073] Furthermore, as types of diaphragm valve 21, especially types based on the mode of operation, there can be manually operated valves and air-operated flow control valves, etc., but from the perspective of facilitating the adjustment of pressure and flow in the flow path, air-operated flow control valves are more preferred.
[0074] The operation of the diaphragm valve 21 , more specifically, the opening and closing of the diaphragm, is controlled by the control unit 27 .
[0075] exist Figure 1 , an example is shown in which the narrow path portion 14n is formed by the diaphragm valve 21, but the invention is not limited thereto. As an example of a case in which the narrow path portion 14n is formed by a member other than a valve, a method in which the narrow path portion 14n is formed by a reducer can be cited. With this method, the cross-sectional area of the narrow path portion 14n is always constant.
[0076] The liquid ejector 18 is provided on the upstream side of the branch point Pj in the first flow channel 14 , and causes the liquid medicine in the liquid tank 12 to flow in the first flow channel 14 from the outflow end Pd toward the inflow end Pe.
[0077] The liquid ejector 18 is, for example, a pump. The pump is not particularly limited as long as it can make the liquid medicine in the liquid tank 12 flow into the first flow path 14 from the outflow end Pd toward the inflow end Pe. By using the liquid ejector 18 to make the liquid medicine flow in the first flow path 14, the liquid medicine also flows in the second flow path 16 via the branch point Pj of the first flow path 14. In addition, the liquid medicine flowing in the second flow path 16 merges with the liquid medicine flowing in the first flow path 14 at the confluence point Pc of the first flow path 14. As a result, the liquid medicine in the liquid tank 12 flows and circulates in the first flow path 14 and the second flow path 16. At this time, the liquid medicine passes through the filter 20 while flowing in the first flow path 14, thereby removing particles in the liquid medicine.
[0078] The operation of the liquid ejector 18 is controlled by the control unit 27 .
[0079] The filter 20 is disposed between the liquid ejector 18 and the branch point Pj in the first flow path 14. The filter 20 removes particles in the chemical solution.
[0080] The filter 20 has, for example, a pore size corresponding to the minimum size of the particles that can be removed. When the pore size of the filter 20 is 20 nm, particles with a diameter greater than 20 nm can be removed by the sieving effect. In addition, by depositing filter cakes on the filter 20 or by adsorption of particles to the filter 20, particles with a diameter of less than 20 nm can sometimes be removed.
[0081] As the material of the filter 20, for example, polyamides such as 6-nylon and 6,6-nylon, polyethylene, polypropylene, polystyrene, polyimide, polyamide-imide, and fluororesin can be cited. Polyimide and polyamide-imide can also be a material having at least one selected from the group consisting of a carboxyl group, a carboxyl group in the form of a salt, and an -NH- bond. Regarding solvent resistance, fluororesin, polyimide, and polyamide-imide are excellent. In addition, from the viewpoint of adsorbing metal ions, polyamides such as 6-nylon and 6,6-nylon are preferred, and nylon is more preferred.
[0082] The filter 20 may also be a structure having a metal ion adsorption filter and an organic impurity adsorption filter. As the metal ion adsorption filter, a filter capable of ion exchange is preferred. As the metal ion adsorption filter, for example, a polyimide and / or polyamide-imide porous membrane described in Japanese Patent Publication No. 2016-155121 may be cited.
[0083] The organic impurity adsorption filter is not particularly limited, and known organic impurity adsorption filters can be cited. Among them, as the organic impurity adsorption filter, from the viewpoint of improving the adsorption performance of organic impurities, it is preferred that the surface has an organic skeleton that can interact with the organic impurities (in other words, the surface is modified with an organic skeleton that can interact with the organic impurities). The organic impurity adsorption filter can also use a filter in which the activated carbon described in Japanese Patent Publication No. 2002-273123 and Japanese Patent Publication No. 2013-150979 is adhered and fixed on a non-woven fabric.
[0084] The measuring device 22 is disposed in the second flow path 16 and counts the number of particles contained in the chemical solution in the second flow path 16. Specifically, the measuring device 22 is provided in the second pipe 17.
[0085] Data indicating a measured value of the number of particles contained in the chemical solution measured by the measuring device 22 is output to the control unit 27 .
[0086] The measuring device 22 is not particularly limited in structure as long as it can count the number of particles contained in the drug solution in the second flow channel 16 . For example, a light scattering type particle counter or a light shielding type particle counter can be used.
[0087] The liquid medicine flowing into the second flow path 16 from the branch point Pj in the first flow path 14 flows into the measuring device 22 from the liquid medicine inlet Pi of the measuring device 22 , flows out from the liquid medicine outlet Po of the measuring device 22 , and returns to the first flow path 14 from the confluence point Pc in the first flow path 14 .
[0088] The discharge flow path 24 is connected to the first flow path 14 via the valve 26 and is used to discharge the drug solution to the outside of the first flow path 14. The discharge flow path 24 has, for example, a straight portion 24a and a curved portion 24b curved relative to the straight portion 24a. The angle of the curved portion 24b relative to the straight portion 24a is, for example, 90°.
[0089] The discharge flow path 24 is constituted by, for example, a discharge pipe 25. The discharge flow path 24 is formed in the discharge pipe 25. The discharge pipe 25 has a straight pipe portion 25a and a bent pipe portion 25b bent relative to the straight pipe portion 25a, similarly to the discharge flow path 24. The angle of the bent pipe portion 25b relative to the straight pipe portion 25a is, for example, 90°.
[0090] The straight pipe portion 25a of the discharge pipe 25 is connected to the first pipe 15 via a valve 26. The bent pipe portion 25b of the discharge pipe 25 is connected to a container 28.
[0091] The valve 26 switches the flow path of the drug solution from the first flow path 14 to the discharge flow path 24. Specifically, the valve 26 is provided at one of the four bends 15e of the first pipe 15. The valve 26 is, for example, a three-way valve. The switching of the flow path of the drug solution by the valve 26 is controlled by the control unit 27.
[0092] Although a three-way valve is shown as the valve 26 , the valve is not particularly limited as long as the flow path of the chemical solution can be switched, and a two-way valve may be provided in each of the first pipe 15 and the discharge pipe 25 .
[0093] The container 28 is a component for storing the drug solution discharged from the discharge flow path 24. As described above, the bent pipe portion 25b of the discharge pipe 25 is connected to the container 28. The container 28 is made of a material corresponding to the composition of the drug solution, etc. In addition, the capacity of the container 28 is appropriately set according to the amount of the drug solution.
[0094] The control unit 27 is connected to the liquid ejector 18 , the diaphragm valve 21 , the measuring device 22 , and the valve 26 , and controls the liquid ejector 18 , the diaphragm valve 21 , the measuring device 22 , and the valve 26 .
[0095] Specifically, the control unit 27 operates the liquid ejector 18 to cause the liquid in the liquid tank 12 to flow into the first flow path 14 from the outflow end Pd toward the inflow end Pe, and stops the operation of the liquid ejector 18 .
[0096] Furthermore, the control unit 27 operates the diaphragm valve 21 to increase or decrease the cross-sectional area of the flow path of the narrow path portion 14n.
[0097] Furthermore, the control unit 27 operates the valve 26 to switch the flow path of the chemical solution from the first flow path 14 to the discharge flow path 24 , and to switch the flow path of the chemical solution from the discharge flow path 24 to the first flow path 14 .
[0098] The control unit 27 stores a threshold value of the number of particles contained in the drug solution. In addition, data indicating the measured value of the number of particles of the measuring device 22 is received. In the control unit 27, the measurement result of the number of particles of the measuring device 22 is compared with the threshold value set for the number of particles contained in the drug solution. When the number of particles is less than the threshold value, the valve 26 is operated to switch the flow path of the drug solution from the first flow path 14 to the discharge flow path 24. Thus, the manufactured drug solution is filled into the container 28.
[0099] After the manufactured chemical solution is filled into the container 28 , the control unit 27 operates the valve 26 again to switch the flow path of the chemical solution from the discharge flow path 24 to the first flow path 14 .
[0100] The measuring apparatus 10 for producing particles in a semiconductor chemical solution further includes a raw material supply unit 29. The raw material supply unit 29 includes a first tank 30, a second tank 32, and a third tank 34, for example.
[0101] The first tank 30 and the liquid tank 12 are connected by a pipe 31a. A pump 31b and a valve 31c are provided on the pipe 31a in this order from the first tank 30 side. The first tank 30 stores a raw material liquid.
[0102] The second tank 32 and the liquid tank 12 are connected by a pipe 33a. A pump 33b and a valve 33c are provided on the pipe 33a in this order from the second tank 32 side. The second tank 32 stores the raw material liquid.
[0103] The third tank 34 and the liquid tank 12 are connected by a pipe 35a. A pump 35b and a valve 35c are provided on the pipe 35a in this order from the third tank 34 side. The third tank 34 stores a raw material liquid.
[0104] The raw material liquids stored in the first tank 30, the second tank 32, and the third tank 34 are one form of the raw material of the liquid medicine. The raw material liquid is a liquid obtained by mixing the raw material of the liquid medicine with a solvent (for example, water).
[0105] The chemical solution is obtained by mixing the raw material solutions from the first tank 30 , the second tank 32 , and the third tank 34 in the liquid tank 12 .
[0106] Although the first tank 30, the second tank 32 and the third tank 34 are provided, the liquid medicine may be a liquid medicine obtained by mixing two or more raw materials in a liquid tank. In this case, at least two tanks for storing a raw material liquid in one form of the raw material are sufficient.
[0107] Alternatively, a raw material liquid itself may be used as a chemical liquid. In this case, at least one tank storing the raw material liquid may be sufficient.
[0108] The raw material supply unit 29 is not limited to the structure including the first tank 30 , the second tank 32 , and the third tank 34 , and the number of tanks and the like may be appropriately determined according to the composition of the chemical solution.
[0109] Alternatively, a configuration without the raw material supply unit 29 may be adopted.
[0110] In addition, the above-mentioned pumps, valves, pipes, valves, liquid tanks, tanks, and containers can appropriately utilize those known in the relevant technical field.
[0111] From the viewpoint of achieving a more excellent effect of the present invention, the ratio (A2 / A1) of the cross-sectional area A2 of the narrow passage 14n to the cross-sectional area A1 of the first flow path 14 on the upstream side of the branch point Pj of the first flow path 14 is preferably 0.75 or less, more preferably 0.50 or less, and even more preferably 0.25 or less. From the viewpoint of further improving the production efficiency of the drug solution, the lower limit is preferably 0.15 or more.
[0112] In addition, when the cross-sectional area of the first flow path 14 on the upstream side of the branch point Pj of the first flow path 14 varies depending on the position, the above-mentioned cross-sectional area ratio is calculated based on the part with the smallest cross-sectional area among the cross-sectional areas of the first flow path 14 on the upstream side of the branch point Pj of the first flow path 14.
[0113] When the cross-sectional area of the narrow portion 14n differs according to the position, the cross-sectional area ratio is calculated based on the position with the smallest cross-sectional area among the cross-sectional areas of the narrow portion 14n.
[0114] The narrow passage 14n is preferably provided on the branch point Pj side relative to the middle position between the branch point Pj and the confluence point Pc in the first flow path 14. Thus, the pressure in the second flow path 16 can be further increased. As a result, the size of the bubbles contained in the liquid medicine in the second flow path 16 becomes smaller, so that the number of particles can be measured more accurately.
[0115] Specifically, from the viewpoint of being able to more accurately measure the number of particles, the ratio (X2 / X1) of the length X2 from the branch point Pj to the narrow passage 14n in the first flow path 14 to the length X1 from the branch point Pj to the confluence point Pc in the first flow path 14 is preferably less than 0.50, more preferably 0.40 or less, and even more preferably 0.30 or less. There is no particular limitation on the lower limit as long as the valve can be arranged.
[0116] The ratio (A3 / A1) of the cross-sectional area A3 of the second flow path 16 to the cross-sectional area A1 of the first flow path 14 on the upstream side of the branch point Pj of the first flow path 14 is preferably 0.50 or less, more preferably 0.25 or less, and further preferably 0.20 or less. Thus, the size of the bubbles becomes smaller due to the increase in the pressure of the liquid medicine flowing into the second flow path 16, so that the number of particles can be measured more accurately.
[0117] From the viewpoint of being able to sufficiently supply the chemical solution to the measuring device 22 , the lower limit of the ratio (A3 / A1) is preferably 0.03 or more.
[0118] When the cross-sectional area of the second flow channel 16 differs according to the position, the cross-sectional area ratio is calculated based on the position having the largest cross-sectional area among the cross-sectional areas of the second flow channel 16 .
[0119] In addition, when the cross-sectional area of the first flow path 14 on the upstream side of the branch point Pj of the first flow path 14 varies depending on the position, the above-mentioned cross-sectional area ratio is calculated based on the part with the smallest cross-sectional area among the cross-sectional areas of the first flow path 14 on the upstream side of the branch point Pj of the first flow path 14.
[0120] In the device 10 for measuring particles in a semiconductor manufacturing liquid, the liquid in the liquid tank 12 is discharged from the outflow end Pd by the liquid ejector 18 and flows into the first flow path 14, and is returned to the inflow end Pe of the liquid tank 12 via the first flow path 14 and the second flow path 16 through the filter 20. At this time, the number of particles in the liquid is measured by the measuring device 22. The liquid is circulated in the first flow path 14 and the second flow path 16 until the number of particles is less than a predetermined number. When the number of particles is less than a predetermined number, the flow path of the liquid is switched from the first flow path 14 to the discharge flow path 24 by the valve 26, and the liquid is filled into the container 28. In this way, a liquid for semiconductor manufacturing can be obtained.
[0121] Filtration method for chemical liquid used in semiconductor manufacturing
[0122] The above-mentioned device 10 for measuring particles in a semiconductor manufacturing chemical solution has a structure including a filter 20 and can be used as a device used for filtering a chemical solution.
[0123] The method for filtering a chemical solution for semiconductor manufacturing includes a step of filtering the chemical solution using the above-mentioned device 10 for measuring particles in a chemical solution for semiconductor manufacturing.
[0124] In the method for filtering a chemical solution for semiconductor manufacturing, for example, the control unit 27 compares the measurement result of the number of particles of the measuring device 22 with a threshold value set for the number of particles contained in the chemical solution, and performs filtration of the chemical solution until the number of particles in the chemical solution is less than the threshold value. In this way, a chemical solution containing a number of particles less than the threshold value can be obtained.
[0125] Method for producing chemical solution for semiconductor manufacturing
[0126] The above-mentioned device 10 for measuring particles in a semiconductor manufacturing chemical solution can be used as a device used in the manufacture of a semiconductor manufacturing chemical solution.
[0127] The method for manufacturing a chemical solution for semiconductor manufacturing has a step of manufacturing a chemical solution by mixing two or more raw materials using the above-mentioned measuring device 10 for measuring particles in a semiconductor chemical solution. As described above, in the manufacture of the chemical solution, for example, a raw material liquid can be used as described above, but the raw material itself of the chemical solution can also be used.
[0128] In the method for manufacturing a chemical solution for semiconductor manufacturing, for example, raw material solutions from a first tank 30, a second tank 32, and a third tank 34 are mixed in a liquid tank 12 to obtain a chemical solution. The mixed chemical solution is circulated in a first flow path 14 by a liquid ejector 18, and the chemical solution is circulated through a filter 20 until the number of particles contained in the chemical solution is less than a threshold value.
[0129] In the method for manufacturing a chemical solution for semiconductor manufacturing, for example, the control unit 27 compares the measurement result of the number of particles of the measuring device 22 with a threshold value set for the number of particles contained in the chemical solution, and when the number of particles in the chemical solution is less than the threshold value, the valve 26 is operated to switch the flow path of the chemical solution from the first flow path 14 to the discharge flow path 24, and the manufactured chemical solution is filled into the container 28. In this way, the chemical solution for semiconductor manufacturing can be manufactured.
[0130] Semiconductor substrate cleaning method
[0131] The chemical solution obtained by using the above-mentioned device 10 for measuring particles in a semiconductor chemical solution can be used, for example, for cleaning a semiconductor substrate. In this case, the components of the chemical solution are made suitable for cleaning a semiconductor substrate. The chemical solution thus produced is filled into a container 28 (see Figure 1 ). The chemical liquid in the container 28 is supplied as a cleaning liquid to the semiconductor substrate for cleaning. In addition to the semiconductor substrate, the chemical liquid can also be used as a cleaning liquid for semiconductor manufacturing equipment, for example.
[0132] Semiconductor components
[0133] The semiconductor element is not particularly limited. More specifically, the semiconductor element includes, for example, a logic LSI (Large Scale Integration), an ASIC (Application Specific Integrated Circuit), an FPGA (Field Programmable Gate Array), an ASSP (Application Specific Standard Product), a microprocessor (for example, a CPU, a GPU, etc.), a memory (for example, a DRAM (Dynamic Random Access Memory), an SRAM (Static Random Access Memory), an HMC (Hybrid Memory Cube), an MRAM (Magnetic RAM), a PCM (Phase-Change Memory), a ReRAM (Resistive RAM), a FeRAM (Ferroelectric RAM), a flash memory, etc.), an LED (Light Emitting Diode), a power device, an analog IC (Integrated Circuit), for example, a DC (Direct Current)-DC (Direct Current) converter, an insulated gate bipolar transistor (IGBT), a MEMS (Micro Electro Mechanical Systems) such as an acceleration sensor, a pressure sensor, a vibrator, a gyro sensor, etc., for example, a GPS (Global Positioning System), an FM (Frequency Modulation), an NFC (Near Field Communication), an RFEM (RF Expansion Module), an MMIC (Monolithic Microwave Integrated Circuit), WLAN (Wireless Local Area Network), discrete components, BSI (Back Side Illumination), CIS (Contact Image Sensor), camera modules, passive devices, SAW (Surface Acoustic Wave) filters, RF (Radio Frequency) filters, RFIPD (Radio Frequency Integrated Passive Devices), BB (Broadband), etc.
[0134] The composition of the semiconductor constituting the semiconductor element is not particularly limited. Examples of the composition of the semiconductor include diamond, silicon (Si), germanium (Ge), silicon germanium (SiGe), silicon carbide (SiC), gallium arsenide (GaAs), gallium nitride (GaN), gallium oxide, and silicon on insulator (SOI).
[0135] Liquid
[0136] The chemical solution used in the device for measuring particles in a semiconductor chemical solution of the present invention preferably contains water.
[0137] water
[0138] There is no particular limitation on the water as long as it does not affect the semiconductor substrate, and distilled water, ion-exchanged water, and pure water (ultrapure water) can be used. From the viewpoint of having less influence on the semiconductor substrate in the manufacturing process of the semiconductor element, pure water or ion-exchanged water is preferred.
[0139] The water content may be the remainder of the components that can be contained in the drug solution.
[0140] The content of water is preferably 50.0 to 99.99% by mass, more preferably 60.0 to 98.0% by mass, and even more preferably 65.0 to 85.0% by mass, based on the total mass of the chemical solution.
[0141] Surfactants
[0142] From the viewpoint of achieving better cleaning performance, the chemical solution preferably contains a surfactant.
[0143] The surfactant is not particularly limited as long as it is a compound having a hydrophilic group and a hydrophobic group (lipophilic group) in one molecule, and examples thereof include nonionic surfactants and anionic surfactants.
[0144] Many surfactants have at least one hydrophobic group selected from the group consisting of an aliphatic hydrocarbon group, an aromatic hydrocarbon group, and a combination thereof.
[0145] The surfactant as a whole preferably has 16 to 100 carbon atoms.
[0146] Examples of the nonionic surfactant include ester-type nonionic surfactants, ether-type nonionic surfactants, and ester-ether-type nonionic surfactants, and ether-type nonionic surfactants are preferred.
[0147] As the nonionic surfactant, for example, the compounds exemplified in paragraph 0126 of International Publication No. 2022 / 044893 can also be cited, and the contents thereof are incorporated into the present specification.
[0148] Examples of the anionic surfactant include phosphate surfactants having a phosphate group, sulfonic acid surfactants having a sulfonic group, phosphonic acid surfactants having a phosphonic acid group, carboxylic acid surfactants having a carboxyl group, and sulfate surfactants having a sulfate group.
[0149] As the anionic surfactant, for example, the compounds exemplified in paragraphs 0116 to 0123 of International Publication No. 2022 / 044893 can also be cited, and the contents thereof are incorporated into the present specification.
[0150] The content of the surfactant is preferably 0.0001 to 1.0% by mass, more preferably 0.001 to 0.8% by mass, based on the total mass of the drug solution.
[0151] The surfactant may be used alone or in combination of two or more. When two or more surfactants are used, the total content is preferably within the above range.
[0152] Organic Acid
[0153] From the viewpoint of improving the removal performance of metal-containing substances, the chemical solution preferably contains an organic acid.
[0154] An organic acid is an organic compound having an acidic functional group and showing acidity (pH less than 7.0) in an aqueous solution. Examples of the acidic functional group include a carboxyl group, a phosphonic acid group, a sulfonic acid group, a phenolic hydroxyl group, and a mercapto group.
[0155] In addition, in this specification, the compound which functions as the above-mentioned anionic surfactant is not included in the organic acid.
[0156] The organic acid is not particularly limited, and examples thereof include carboxylic acids having a carboxyl group in the molecule (organic carboxylic acids), phosphonic acids having a phosphonic acid group in the molecule (organic phosphonic acids), and sulfonic acids having a sulfonic group in the molecule (organic sulfonic acids). Carboxylic acids or phosphonic acids are preferred.
[0157] The number of functional groups possessed by the organic acid is not particularly limited, but is preferably 1 to 4, and more preferably 1 to 3.
[0158] In addition, from the viewpoint of better cleaning performance, the organic acid is preferably a compound having a function of chelating with the metal contained in the residue, and more preferably a compound having two or more functional groups (ligands) in the molecule that coordinate and bond with metal ions. As the ligand, the above-mentioned acidic functional groups can be cited, preferably a carboxylic acid group or a phosphonic acid group.
[0159] carboxylic acid
[0160] The carboxylic acid may be a monocarboxylic acid having one carboxyl group or a polycarboxylic acid having two or more carboxyl groups. From the viewpoint of better cleaning performance, a polycarboxylic acid having two or more (more preferably 2 to 4, and even more preferably 2 or 3) carboxyl groups is preferred.
[0161] Examples of the carboxylic acid include aminopolycarboxylic acids, amino acids, hydroxycarboxylic acids, and aliphatic carboxylic acids.
[0162] Aminopolycarboxylic acid
[0163] Aminopolycarboxylic acid is a compound having one or more amino groups and two or more carboxyl groups as ligands in the molecule.
[0164] Examples of the aminopolycarboxylic acid include aspartic acid, glutamic acid, butanediaminetetraacetic acid, diethylenetriaminepentaacetic acid (DTPA), ethylenediaminetetrapropionic acid, triethylenetetraaminehexaacetic acid, 1,3-diamino-2-hydroxypropane-N,N,N',N'-tetraacetic acid, propylenediaminetetraacetic acid, ethylenediaminetetraacetic acid (EDTA), trans-1,2-diaminocyclohexanetetraacetic acid (CyDTA), ethylenediaminediacetic acid, ethylenediaminedipropionic acid, 1,6-hexamethylene-diamine-N,N,N',N'-tetraacetic acid, N,N-bis(2-hydroxybenzyl)ethylenediamine-N,N-diacetic acid, diaminopropanetetraacetic acid, 1,4,7,10-tetraazacyclododecane-tetraacetic acid, diaminopropanoltetraacetic acid, (hydroxyethyl)ethylenediaminetriacetic acid, and iminodiacetic acid (IDA).
[0165] Among them, DTPA, EDTA, CyDTA or IDA is preferred.
[0166] Amino Acids
[0167] Amino acids are compounds that have one carboxyl group and one or more amino groups in their molecules.
[0168] As amino acid, for example, glycine, serine, α-alanine (2-aminopropionic acid), β-alanine (3-aminopropionic acid), lysine, leucine, isoleucine, cystine, cysteine, methionine, ethionine, threonine, tryptophan, tyrosine, valine, histidine, histidine derivatives, asparagine, glutamine, arginine, proline, phenylalanine, the compounds described in paragraphs 0021 to 0023 of Japanese Patent Publication No. 2016-086094, and their salts. In addition, as histidine derivatives, compounds described in Japanese Patent Publication No. 2015-165561 and Japanese Patent Publication No. 2015-165562 can be cited, and their contents are introduced into this specification. In addition, as salt, alkali metal salts such as sodium salts and potassium salts, ammonium salts, carbonates, and acetates can be mentioned.
[0169] Among them, histidine, histidine derivatives, or sulfur-containing amino acids containing sulfur atoms are preferred, and histidine or sulfur-containing amino acids are more preferred. Examples of sulfur-containing amino acids include cystine, cysteine, ethionine, and methionine, and cystine or cysteine is preferred.
[0170] Hydroxycarboxylic acid
[0171] Hydroxycarboxylic acids are compounds having one or more hydroxyl groups and one or more amino groups in the molecule.
[0172] Examples of the hydroxycarboxylic acid include malic acid, citric acid, glycolic acid, gluconic acid, heptanoic acid, tartaric acid and lactic acid. Gluconic acid, glycolic acid, malic acid, tartaric acid or citric acid is preferred, and gluconic acid or citric acid is more preferred.
[0173] Aliphatic carboxylic acid
[0174] Examples of the aliphatic carboxylic acid include oxalic acid, malonic acid, succinic acid, glutaric acid, adipic acid, pimelic acid, sebacic acid, and maleic acid. Adipic acid is preferred from the viewpoint of enhancing the effect of the present invention and the cleaning property.
[0175] Examples of carboxylic acids other than the above-mentioned aminopolycarboxylic acids, amino acids, hydroxycarboxylic acids, and aliphatic carboxylic acids include monocarboxylic acids.
[0176] Examples of the monocarboxylic acid include lower (having 1 to 4 carbon atoms) aliphatic monocarboxylic acids such as formic acid, acetic acid, propionic acid and butyric acid.
[0177] The carboxylic acid is preferably an amino acid, a hydroxycarboxylic acid or an aliphatic carboxylic acid, more preferably cystine, cysteine, histidine, gluconic acid, glycolic acid, malic acid, tartaric acid, citric acid or adipic acid, further preferably cysteine, gluconic acid, citric acid or adipic acid.
[0178] The carboxylic acids may be used alone or in combination of two or more.
[0179] The content of the carboxylic acid is not particularly limited, but is preferably 0.1 to 35.0% by mass, more preferably 1.0 to 35.0% by mass, relative to the total mass of the chemical solution.
[0180] Phosphonic acid
[0181] The phosphonic acid may be a monophosphonic acid having one phosphonic acid group or a polyphosphonic acid having two or more phosphonic acid groups. From the viewpoint of better cleaning performance, a polyphosphonic acid having two or more phosphonic acid groups is preferred.
[0182] As the polyphosphonic acid, the substances represented by the general formulas 1 to 3 described in paragraphs 0013 to 0023 of the specification of International Publication No. 2013 / 162020, the substances described in paragraphs 0026 to 0036 of the specification of International Publication No. 2018 / 020878, and the compounds ((co)polymers) described in paragraphs 0031 to 0046 of the specification of International Publication No. 2018 / 030006 can be cited, and their contents are incorporated into the present specification.
[0183] Examples of the polyphosphonic acid include ethylenediphosphonic acid, 1-hydroxyethylidene-1,1'-diphosphonic acid (HEDPO), 1-hydroxypropylene-1,1'-diphosphonic acid, 1-hydroxybutylene-1,1'-diphosphonic acid, ethylaminobis(methylenephosphonic acid), dodecylaminobis(methylenephosphonic acid), nitrilotri(methylenephosphonic acid) (NTPO), ethylenediaminebis(methylenephosphonic acid) (EDDPO), 1,3-propylenediaminebis(methylenephosphonic acid), ethylenediaminetetra( 1,3-propylenediaminetetrakis(methylenephosphonic acid) (PDTMP), 1,2-diaminopropanetetrakis(methylenephosphonic acid), 1,6-hexamethylenediaminetetrakis(methylenephosphonic acid), diethylenetriaminepenta(methylenephosphonic acid) (DEPPO), diethylenetriaminepenta(ethylenephosphonic acid), triethylenetetraaminehexa(methylenephosphonic acid) and triethylenetetraaminehexa(ethylenephosphonic acid), preferably HEDPO.
[0184] The number of phosphonic acid groups contained in phosphonic acid is preferably 2 to 5, more preferably 2 to 4, and even more preferably 2 or 3.
[0185] The number of carbon atoms in the phosphonic acid is preferably 12 or less, more preferably 10 or less, and even more preferably 8 or less. The lower limit is not particularly limited, but is preferably 1 or more.
[0186] The phosphonic acid may be used alone or in combination of two or more.
[0187] The content of phosphonic acid is not particularly limited, but is preferably 0.001 to 5.0% by mass, more preferably 0.01 to 2.0% by mass, based on the total mass of the chemical solution.
[0188] The organic acid preferably has a low molecular weight. More specifically, the molecular weight of the organic acid is preferably 600 or less, more preferably 450 or less, and further preferably 300 or less. The lower limit is not particularly limited, but is preferably 85 or more.
[0189] The number of carbon atoms in the organic acid is preferably 15 or less, more preferably 12 or less, and even more preferably 8 or less. The lower limit is not particularly limited, but is preferably 1 or more.
[0190] The organic acid may be used alone or in combination of two or more.
[0191] The content of the organic acid is not particularly limited, but is preferably 0.1 to 40% by mass, more preferably 1.0 to 35% by mass, based on the total mass of the drug solution.
[0192] From the viewpoint of achieving better cleaning performance, the chemical solution preferably contains carboxylic acid and phosphonic acid.
[0193] Other Ingredients
[0194] The drug solution may contain components other than those described above (hereinafter also referred to as “other components”).
[0195] Other components include pH adjusters (e.g., alkaline compounds and acidic compounds), organic solvents (e.g., alcohol solvents, glycol solvents, glycol ether solvents, and ketone solvents), water-soluble polymers (e.g., water-soluble polymers described in paragraphs 0043 to 0047 of JP-A-2016-171294), and oxidants (e.g., peroxides, persulfides, and percarbonates, acids thereof, and salts thereof).
[0196] Physical properties of the drug solution
[0197] The properties of the drug solution are described in detail below.
[0198] pH
[0199] The drug solution may be either alkaline or acidic.
[0200] The pH of the drug solution is preferably 0.10 to 4.00.
[0201] The pH of the drug solution can be adjusted using the above-mentioned pH adjuster.
[0202] The pH of the chemical solution can be measured using a known pH meter by a method in accordance with JIS Z8802-1984. The measurement temperature was set at 25°C.
[0203] Metal content
[0204] The content (measured as ion concentration) of metals (e.g., metal elements such as Fe, Co, Na, Cu, Mg, Mn, Li, Al, Cr, Ni, Zn, Sn, and Ag) contained as impurities in the chemical solution is preferably 5 mass ppm or less, and more preferably 1 mass ppm or less. In the manufacture of the most advanced semiconductor elements, since a chemical solution with a higher purity is assumed to be required, the metal content is further preferably a value lower than 1 mass ppm, that is, a mass ppb level or less, particularly preferably 100 mass ppb or less, and most preferably less than 10 mass ppb. As the lower limit, 0 is preferred.
[0205] Examples of methods for reducing the metal content include purification treatment such as distillation or filtration using an ion exchange resin or a filter at the stage of the raw material (eg, raw material solution) used in the production of the chemical solution or after the production of the chemical solution.
[0206] As another method of reducing the metal content, it is possible to use a container with less impurity dissolution as described below as a container for storing raw materials or manufactured liquid medicine. In addition, in order to prevent the metal component from dissolving from the piping, etc. when manufacturing the liquid medicine, it is also possible to line the inner wall of the piping with fluororesin.
[0207] Coarse particles
[0208] The drug solution may contain coarse particles, but the content thereof is preferably low.
[0209] The coarse particles are particles having a diameter (particle size) of 0.03 μm or more when the particle shape is regarded as a sphere.
[0210] The coarse particles contained in the drug solution refer to particles of dust, dirt, organic solids, inorganic solids, etc. contained as impurities in the raw materials, as well as particles of dust, dirt, organic solids, inorganic solids, etc. brought in as contaminants during the preparation of the drug solution. They are equivalent to substances that ultimately do not dissolve in the drug solution and exist as particles.
[0211] The content of coarse particles in the drug solution is preferably 10,000 or less, more preferably 5,000 or less, per 1 mL of the drug solution. The lower limit is preferably 0 or more, more preferably 0.01 or more, per 1 mL of the drug solution.
[0212] The content of coarse particles present in the drug solution can be measured in a liquid phase using a commercially available measuring device of a light scattering liquid particle measuring method using laser light as a light source.
[0213] As a method for removing coarse particles, for example, purification treatment such as filtration is mentioned.
[0214] Method for producing liquid medicine
[0215] The chemical solution used in the device for measuring particles in semiconductor chemical solution of the present invention can be produced by a known method. Hereinafter, the method for producing the chemical solution used in the device for measuring particles in semiconductor chemical solution of the present invention will be described in detail.
[0216] Liquid adjustment process
[0217] The drug solution can be produced by mixing the above-mentioned components, for example.
[0218] As a method for preparing the liquid medicine, for example, the following method can be mentioned: after adding the above-mentioned components in a container containing purified pure water, stirring and mixing, and adding a pH adjuster as needed to adjust the pH of the mixed solution, thereby preparing the liquid medicine. In addition, when adding water and each component to the container, they can be added all at once or in multiple times.
[0219] The stirring device and stirring method used in the preparation of the liquid medicine can be any known device as a stirrer or a disperser. Examples of stirrers include industrial mixers, portable stirrers, mechanical stirrers, and magnetic stirrers. Examples of dispersers include industrial dispersers, homogenizers, ultrasonic dispersers, and bead mills.
[0220] The liquid medicine stored in the liquid tank of the device for measuring particles in liquid medicine for semiconductor manufacturing of the present invention may be a liquid medicine obtained by mixing two or more raw material liquids in the liquid tank. That is, the liquid medicine used in the device for measuring particles in liquid medicine for semiconductor manufacturing of the present invention may be a liquid medicine prepared in the liquid tank.
[0221] The two or more raw material solutions preferably contain components different from each other.
[0222] Specific examples of the raw material liquid include a liquid containing at least one selected from the group consisting of the above-mentioned surfactant, organic acid and other components and water.
[0223] refined
[0224] It is preferred that at least one of the raw materials used to prepare the drug solution be subjected to a purification treatment in advance. Examples of the purification treatment include known methods such as distillation, ion exchange, and filtering.
[0225] The degree of purification is preferably such that the purity of the raw material is 99% by mass or more, more preferably such that the purity of the raw material is 99.9% by mass or more, and the upper limit is preferably 99.9999% by mass or less.
[0226] Examples of the purification method include a method of passing the raw material through an ion exchange resin or an RO membrane (Reverse Osmosis Membrane), distillation of the raw material, and filtration described below.
[0227] As a purification treatment, a plurality of the above-mentioned purification methods may be combined and implemented. For example, the raw material may be purified once by passing it through an RO membrane and then purified twice by passing it through a purification device composed of a cation exchange resin, an anion exchange resin or a mixed bed type ion exchange resin.
[0228] Furthermore, the purification treatment may be performed multiple times.
[0229] As a filter for filtering, there is no particular limitation as long as it is a filter that has been used for filtering purposes. For example, filters composed of fluororesins such as polytetrafluoroethylene (PTFE) and tetrafluoroethylene-perfluoroalkyl vinyl ether copolymer (PFA), polyamide resins such as nylon, and polyolefins such as polyethylene and polypropylene (PP) (including high-density or ultra-high molecular weight) can be cited. Among these materials, it is preferred to select materials from the group consisting of polyethylene, polypropylene (including high-density polypropylene), fluororesins (including PTFE and PFA), and polyamide resins (including nylon), and fluororesin filters are more preferred. By using filters formed from these materials to filter raw materials, foreign matter with high polarity that is likely to cause defects can be effectively removed.
[0230] Uses of liquid medicine
[0231] The chemical solution obtained by using the above-mentioned semiconductor chemical solution particle measurement apparatus 10 is preferably used as a cleaning solution, and more preferably used as a cleaning solution used in a cleaning process performed after a chemical mechanical polishing (CMP) process.
[0232] When a chemical liquid is used as a cleaning liquid, the object to be cleaned is preferably a semiconductor substrate, and more preferably a semiconductor substrate subjected to a CMP process.
[0233] Example
[0234] The present invention will be described in more detail below based on examples. As long as it does not depart from the gist of the present invention, the materials, dosages, ratios, processing contents and processing sequences shown in the following examples may be appropriately changed. Therefore, the scope of the present invention should not be limited to the following examples.
[0235] Preparation of liquid medicine
[0236] Citric acid, 1-hydroxyethylidene-1,1'-diphosphonic acid (hereinafter also referred to as "HEDPO"), a sulfonic acid surfactant and water were added to a liquid tank in an apparatus used in each of the following Examples and Comparative Examples according to the contents shown in Table 1 and mixed to obtain a chemical solution 1.
[0237] Here, the sulfonic acid surfactants were mixed with each surfactant (LAS-10 to LAS-14) at the ratio shown in the "Ratio" column of Table 1, and mixed so as to have the content (0.01% by mass) shown in Table 1. In addition, the "Ratio" column shows the content (% by mass) of each surfactant (LAS-10 to LAS-14) relative to the total mass of the sulfonic acid surfactants.
[0238] Element
[0239] The components used for preparing the drug solution 1 are shown below.
[0240] Citric Acid
[0241] 30 mass% citric acid aqueous solution
[0242] The citric acid content shown in Table 1 is the content of citric acid itself relative to the total mass of the chemical solution 1, and water in the aqueous solution is not included in the citric acid content.
[0243] HEDPO
[0244] 60 mass% 1-hydroxyethylidene-1,1'-diphosphonic acid aqueous solution
[0245] The HEDPO content shown in Table 1 is the content of HEDPO itself relative to the total mass of the chemical solution 1, and water in the aqueous solution is not included in the HEDPO content.
[0246] Sulfonic acid surfactant
[0247] LAS-10: Sulfonic acid A
[0248] LAS-11: Sulfonic acid B
[0249] LAS-12: Sulfonic acid C
[0250] LAS-13: Sulfonic acid D
[0251] Chemical formula 1
[0252]
[0253] water
[0254] Ultrapure water
[0255] Table 1
[0256]
[0257] Example 1
[0258] As a device for measuring particles in a semiconductor liquid prepared as Example 1, a liquid tank, a first flow path (first piping), a narrow path (diaphragm valve), a second flow path (second piping), a liquid ejector, a filter, and a measuring device are manufactured. Figure 1 The configuration of the measuring device is shown.
[0259] In addition, the diaphragm valve is arranged so that the ratio (X2 / X1) of the length X2 from the branch point to the narrow passage in the first flow path to the length X1 from the branch point to the confluence point in the first flow path becomes the value described in Table 2. In addition, the length X2 from the branch point to the narrow passage in the first flow path is 150 mm. In addition, the length X1 from the branch point to the confluence point in the first flow path is 500 mm.
[0260] The opening of the diaphragm valve was adjusted so that the ratio (A2 / A1) of the cross-sectional area A2 of the narrow passage to the cross-sectional area A1 of the first flow path upstream of the branch point of the first flow path became the value shown in Table 2.
[0261] Table 2 shows the ratio (A3 / A1) of the cross-sectional area A3 of the second flow path to the cross-sectional area A1 of the first flow path on the upstream side of the branch point of the first flow path.
[0262] The specifications of the main parts constituting the semiconductor manufacturing chemical solution manufacturing apparatus of Example 1 are as follows.
[0263] Diameter of the first pipe: 25A (inner diameter (diameter of flow path): 27.6mm, outer diameter (diameter of pipe): 34mm)
[0264] The diameter of the second piping: 15A (inner diameter (diameter of the flow path): 16.1 mm, outer diameter (diameter of the piping): 21.7 mm). The diameter of the second piping that is connected to the liquid inlet of the measuring device is 1 / 4 inch (inner diameter (diameter of the flow path): 9.2 mm, outer diameter (diameter of the piping): 13.8 mm).
[0265] Diaphragm valve: Linear diaphragm valve (500 type), model: B459 (DS) N-TX / CE-025-J10KRF, made by Taiya Co., Ltd., Japan
[0266] Measuring instrument: PMS Ultra Chem40, manufactured by Spectris Corporation
[0267] Filter: 1.2 μm polypropylene, model: PG12020T1, manufactured by Entegris
[0268] Embodiment 2-3
[0269] Using the same device for measuring particles in semiconductor solution as in Example 1, the opening of the diaphragm valve is adjusted so that the ratio (A2 / A1) of the cross-sectional area A2 of the narrow path portion to the cross-sectional area A1 of the first flow path on the upstream side of the branching point of the first flow path becomes the value shown in Table 2, and the device for measuring particles in semiconductor solution of Examples 2 and 3 is manufactured.
[0270] Example 4
[0271] The device for measuring particles in semiconductor liquid was manufactured in the same manner as in Example 2, except that the diaphragm valve was arranged so that the ratio (X2 / X1) of the length X2 from the branch point to the narrow path in the first flow path to the length X1 from the branch point to the confluence point in the first flow path became the value described in Table 2. In addition, the length X2 from the branch point to the narrow path in the first flow path was 350 mm. In addition, the length X1 from the branch point to the confluence point in the first flow path was 500 mm.
[0272] Example 5
[0273] A device for measuring particles in a semiconductor chemical solution according to Example 5 was manufactured in the same manner as in Example 2 except that the second pipe described below was used.
[0274] The diameter of the second piping: 10A (inner diameter (diameter of the flow path): 12.7 mm, outer diameter (diameter of the piping): 17.3 mm). The diameter of the second piping that is connected to the liquid inlet of the measuring device is 1 / 4 inch (inner diameter (diameter of the flow path): 9.2 mm, outer diameter (diameter of the piping): 13.8 mm).
[0275] Comparative Example 1
[0276] A device for measuring particles in a semiconductor chemical solution was manufactured in the same manner as in Example 1 except that the constricted portion (diaphragm valve) was not provided.
[0277] Evaluation test
[0278] Particle number ratio
[0279] The liquid tank of the device for measuring particles in semiconductor liquid of the embodiment and the comparative example was filled with the above-mentioned liquid 1. Then, the following operation was performed: the liquid 1 in the liquid tank was passed through the filter from the outflow end by the liquid ejector, moved in the first flow path and the second flow path, and returned to the inflow end of the liquid tank. In addition, the amount of liquid 1 flowing through the first flow path in one minute (weight basis) was set to 8 kg / minute.
[0280] The number of particles in the drug solution 1 after one hour has passed since the drug solution 1 was made to flow out from the outflow end was measured using a measuring device.
[0281] The results are shown in Table 2. The results are expressed as a ratio relative to the number of particles measured by the particle measuring device for manufacturing semiconductor liquid in Comparative Example 1, which is converted to 1. The smaller the ratio, the smaller the number of bubbles measured as particles, and it can be said that more accurate particle number measurement can be performed.
[0282] Pressure ratio of narrow section
[0283] In the evaluation of the "particle number ratio" described above, the pressure at the branch point in the measurement apparatus for measuring particles in semiconductor solution in the embodiment and the comparative example was measured one hour after the solution 1 flowed out from the outflow end. Specifically, the pressure was measured using a pressure gauge installed at the branch point.
[0284] The results are shown in Table 2. The results are expressed as a ratio to the pressure measured by the measuring device for producing particles in a semiconductor chemical solution in Comparative Example 1, converted to 1.
[0285] Table 2
[0286]
[0287] As shown in Table 2, when using a measuring device for particles in a semiconductor solution having a narrow path (Examples 1 to 5), compared with a measuring device for particles in a semiconductor solution without a narrow path (Comparison Example 1), the influence of bubbles is eliminated by providing the narrow path, and the results show that more accurate particle count measurement can be performed.
[0288] From the comparison of Examples 1 to 3, it is found that when the ratio (A2 / A1) is 0.50 or less (Examples 2 and 3), more accurate measurement of the number of particles can be performed.
[0289] From the comparison between Example 2 and Example 4, it can be seen that when the ratio (X2 / X1) is less than 0.50 (i.e., the narrow path portion is arranged on the branch point side rather than the middle position between the branch point and the confluence point in the first flow path) (Example 2), more accurate particle number measurement can be performed.
[0290] From the comparison between Example 2 and Example 5, it can be seen that when the ratio (A3 / A1) is 0.25 or less (Example 5), more accurate measurement of the number of particles can be performed.
[0291] The above description is only the preferred embodiment of the present application and is not intended to limit the present application. For those skilled in the art, the present application may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present application shall be included in the protection scope of the present application.
Claims
1. A device for measuring particles in a semiconductor liquid. It is characterized in that include: A liquid tank for storing chemical solutions used in semiconductor manufacturing, The liquid tank has an outflow end for the liquid medicine to flow out of the liquid tank and an inflow end for the liquid medicine to flow into the liquid tank; A first flow path connecting the outflow end and the inflow end for the liquid medicine to flow; a second flow path extending from a branch point in the first flow path to a confluence point in the first flow path that is located downstream of the branch point; a liquid ejector disposed in the first flow path on the upstream side of the branch point, so that the liquid medicine in the liquid tank flows into the first flow path from the outflow end toward the inflow end; a filter disposed between the liquid ejector and the branch point in the first flow path; and a measuring device disposed in the second flow path and configured to count the number of particles contained in the drug solution in the second flow path, In the first flow path, a narrow passage portion for pressurizing the second flow path is provided between the branch point and the confluence point. The cross-sectional area of the narrow passage is smaller than the cross-sectional area of the first passage on the upstream side of the branch point of the first passage, and the ratio of the cross-sectional area of the narrow passage to the cross-sectional area of the first passage on the upstream side of the branch point of the first passage is 0.50 or less; The narrow passage portion is provided in the first flow passage on the branch point side relative to a middle position between the branch point and the confluence point.
2. A device for measuring particles in a semiconductor liquid as claimed in claim 1, Features: The narrow passage portion is formed by a valve.
3. A device for measuring particles in a semiconductor liquid as claimed in claim 2, Features: The valve is a diaphragm valve.
4. A device for measuring particles in a semiconductor liquid as claimed in claim 3, Features: The diaphragm valve is an air-operated flow regulating valve.
5. A device for measuring particles in a semiconductor liquid as claimed in claim 1, Features: A ratio of a cross-sectional area of the second flow path to a cross-sectional area of the first flow path on an upstream side of the branch point of the first flow path is 0.25 or less.
6. A device for measuring particles in a semiconductor liquid as claimed in claim 1 or 2, Features: The liquid medicine is a cleaning liquid.
7. A device for measuring particles in a semiconductor liquid as claimed in claim 6, Features: The chemical solution is a cleaning solution used for cleaning performed after the chemical mechanical polishing process.
8. A device for measuring particles in a semiconductor liquid according to claim 1 or 2, Features: The drug solution contains a surfactant.
9. A device for measuring particles in a semiconductor liquid according to claim 1 or 2, Features: The drug solution contains carboxylic acid and phosphonic acid.
10. A device for measuring particles in a semiconductor liquid according to claim 1 or 2, Features: The chemical solution is obtained by mixing two or more raw materials in the liquid tank.
11. An apparatus for producing a chemical solution for semiconductor manufacturing, It is characterized in that Comprising a measuring device as claimed in claim 1 or 2.
12. A method for filtering a liquid medicine, It is characterized in that The method comprises the step of filtering the drug solution using the measuring device according to claim 1 or 2.
13. A method for producing a liquid medicine, It is characterized in that The method comprises the step of mixing two or more raw materials using the measuring device according to any one of claims 1 or 2 to produce the drug solution.
